Drugmaker Glenmark Pharmaceuticals Ltd (GLEN.NS) said on Thursday its European unit had launched a generic version of GlaxoSmithKline's (GSK.L) Malarone malaria treatment medicine, its first generic product in Britain.
Glenmark launched the drug after the revocation of Glaxo's patent on Malarone by the High Court in Britain, the Indian company said in a statement, adding the medicine had sales of $28 million in the year ended September.
(Reporting by Sumeet Chatterjee in MUMBAI; editing by Jane Baird)
India to receive normal rains, not surplus, as La Nina chances fade
MUMBAI/NEW DELHI India will receive normal rainfall over the 2016 monsoon season, not surplus as previously expected, with the chances of a La Nina weather pattern emerging over the period seen as unlikely, three senior officials at state-run weather department said.
Piramal to partner Bain Capital for distressed-debt investment
MUMBAI Piramal Enterprises Ltd said it would partner Bain Capital to invest in distressed assets, becoming the latest entrant in the space as the nation's banks are on a drive to clean up $120 billion of sour debt.
China takes aggressive steps to fend off banking, financial risks
BEIJING/SHANGHAI China took aggressive steps on Wednesday to head off signs of growing risks in its financial and banking system, unveiling detailed rules to curb an unruly peer-to-peer (P2P) lending sector and intervening in its money markets.